Do patients with muscular dystrophy always have an elevated creatine kinase level?

Creatine Kinase Elevation in Muscular Dystrophy

No, patients with muscular dystrophy do not always have elevated CK levels, though the vast majority do, particularly in early disease stages. While markedly elevated CK is a hallmark screening test for Duchenne muscular dystrophy (DMD) and most other muscular dystrophies, CK levels decline significantly with disease progression and age, and can even normalize in advanced stages.

CK Patterns in Duchenne Muscular Dystrophy

Early Disease (Peak Elevation)

• CK levels are markedly increased in early DMD and serve as the primary screening test 1
• Peak CK levels occur between ages 3-5 years, with average values ranging from 27,750-31,173 U/L (normal: 35-174 U/L) 2
• In newborns with DMD, CK-MM (the muscle-specific isoform) is persistently elevated, distinguishing it from transient elevations in healthy newborns 3

Progressive Decline with Age

• CK levels decline progressively with clinical deterioration and increasing age at an average rate of 8.7% per year 2
• The decline is most rapid between ages 7-12 years 4
• This decrease reflects ongoing muscle destruction and replacement with fibrofatty tissue, leaving less viable muscle tissue to release CK 2, 4

Advanced Disease

• In late-stage DMD, particularly in non-ambulatory patients with severe muscle wasting, CK levels may approach or even fall within normal ranges 4, 5
• Lower CK values are associated with worse motor function and increased odds of loss of ambulation 5

Important Clinical Caveats

Diagnostic Implications

• A normal CK level does not exclude muscular dystrophy, particularly in:
  • Advanced disease stages with extensive muscle loss 4, 5
  • Milder dystrophy variants (e.g., some Becker muscular dystrophy cases)
  • Female carriers who may have normal or only mildly elevated CK 6

When CK May Be Misleading

• CK shows significant natural variability (coefficient of variation ~35%) even within the same patient 7
• Physical activity, hospitalization, and other factors can influence CK levels 7
• In rare cases, dystrophinopathy can be confirmed by absent dystrophin protein on muscle biopsy even when genetic testing is negative 1

Diagnostic Algorithm

• When DMD is suspected clinically (Gowers' sign, delayed walking, muscle weakness), proceed with CK testing as the initial screen 1
• If CK is markedly elevated, proceed directly to genetic testing for dystrophin mutations 1
• If clinical suspicion remains high despite normal or borderline CK (especially in older children or those with advanced disease), do not rely on CK alone—proceed to muscle biopsy or genetic testing 1
• In boys older than 10 years with normal muscle function, DMD is highly unlikely 1

Other Muscular Dystrophies

• Facio-scapulo-humeral dystrophy shows elevated CK in 90% of cases (18 of 20 patients), demonstrating that some muscular dystrophies have lower sensitivity for CK elevation 8
• Becker muscular dystrophy typically shows elevated CK, though the pattern and degree may differ from DMD 9

The key clinical takeaway: While elevated CK is an excellent screening tool for muscular dystrophy, normal CK does not exclude the diagnosis, particularly in advanced disease or atypical presentations. Clinical suspicion should drive further diagnostic workup regardless of CK levels.